Consistent with human IPF lungs, bleomycin-treated mouse lungs had reduced numbers of Foxf1-positive endothelial cells and decreased expression of Foxf1 mRNA in these cells (Fig. 2h). The gene discussed is FOXF1; the disease is idiopathic pulmonary fibrosis.